DZNE scientists have identified blood biomarkers for FTD, ALS and PSP (symbolic image). Source: DZNE / Frommann

Blood Markers Detect Rare Forms of Dementia as well as the Neurological Diseases ALS and PSP

In a study with 991 adults, scientists at DZNE show that the most common forms of frontotemporal dementia (FTD) as well as the neurological diseases amyotrophic lateral sclerosis (ALS) and progressive supranuclear palsy (PSP) can be recognised by blood testing. Their procedure is not yet ready for routine medical use, but in the long term it could facilitate disease diagnosis and advance the development of new therapies already now. The findings published in the journal Nature Medicine are based on the measurement of certain proteins in the blood, which serve as biomarkers. The study also involved the University Hospital Bonn (UKB) and other research institutions in Germany and Spain.
 
Link to the DZNE press release